Lawrence Otto Klein, Chief Executive Officer at Oruka Therapeutics, sold ORKA on Jun 15, 2026

Data as of Oct 16

▼ SELL$120K1,729 shares at $69.69Lawrence Otto Klein Chief Executive OfficerORKA Oruka Therapeutics, Inc.

Watch ORKA

Traded: Jun 15, 2026
Disclosed: Jun 15, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

ORKASimilar stocks (XLV — its sector index fund), rebased to ORKA's price on the disclosure day

ORKA since disclosure

+4.5%

after the sale

Similar stocks (XLV) since disclosure

+15.6%

XLV — its sector index fund

Change in closing price from Jun 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on ORKA →